The vision

Today’s Steno Diabetes Centers began as a shared vision between the Novo Nordisk Foundation and the Capital Region of Denmark.

According to that vision, the new centre should provide world-class treatment, conduct world-leading research, and unite the region’s existing competencies and offerings in diabetes.

It should be closely integrated with the rest of the public healthcare system and seek dialogue and partnerships with leaders in diabetes research and treatment in Denmark and beyond.

Finally, it should build on Denmark’s history and expertise in this area to develop tomorrow’s patient-centred treatment and prevention strategies for the benefit of everyone – and cement the country’s position as a global leader in preventing and treating diabetes.

Joint initiatives with each of Denmark’s other four regions soon followed – and later with the Governments of Greenland and the Faroe Islands – all led by a similar vision, but each tailored to the specific needs of the region or country.



Read about the centres

The approach

The centres provide treatment for anyone with type 1 diabetes, children and adolescents with type 2 diabetes, and adults with complications from type 2 diabetes. The focus is two-fold: reducing late-stage complications through person-centred approaches and reducing the number of people who develop diabetes.

The centres generate new knowledge, including early detection and prevention of diabetes, through ground-breaking research and the creation of innovative treatments. They collaborate closely with each other, and with general practitioners, hospitals, universities and other public and private bodies, to develop new approaches, build competencies and disseminate knowledge and treatments across the regions.

In this way, everyone living with diabetes – and those at risk of developing it – benefits from the work of the centres.

The day-to-day operations and standard treatments provided by the Steno Diabetes Centers are funded by the regional authorities in Denmark and the governments in Greenland and the Faroe Islands. These bodies are also responsible for the running of the centres.

Supplementary treatment, prevention initiatives, clinical research, intersectoral collaboration, education and training, and the construction and equipping of new facilities are funded by the Novo Nordisk Foundation.



Read about the impact